Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-13, with 33 holding rows worth $119,231,000.

Accession
0000919574-14-004398
Filed
2014-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2014

A holdings report, 33 entries on the cover page, a total value of $119,231,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $119,234,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS100,000$19,572,000thousands by filing dateput
PROSHARES TR74348A319ULTSHT RUSS2000300,000$12,906,000thousands by filing datecall
iShares Russell 2000 ETF464287655SHS100,000$11,881,000thousands by filing dateput
ALBANY MOLECULAR RESH012423109COMMON STOCK498,200$10,024,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR100,000$7,431,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM199,000$6,854,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR130,000$6,815,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK229,481$4,603,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock77,208$4,531,000thousands by filing date
Merck & Co.,Inc.58933Y105COM77,000$4,454,000thousands by filing date
Pfizer Inc.717081103COM150,000$4,452,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR57,735$3,070,000thousands by filing date
PROSHARES TR74347B409ULTSH NASD BIOT200,000$2,848,000thousands by filing date
PROSHARES TR74347B409ULTSH NASD BIOT200,000$2,848,000thousands by filing datecall
SUPERNUS PHARMACEUTICALS868459108COM200,000$2,190,000thousands by filing datecall
ALBANY MOLECULAR RESH012423109COMMON STOCK100,000$2,012,000thousands by filing datecall
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK100,000$2,006,000thousands by filing datecall
IMPAX LABORATORIES INC45256B101COM50,000$1,500,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK204,968$1,384,000thousands by filing date
PROSHARES TR74348A319ULTSHT RUSS200025,000$1,076,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW150,000$978,000thousands by filing datecall
KINDRED BIOSCIENCES INC COM494577109Stock50,000$932,000thousands by filing date
SUCAMPO PHARMACEUTICALS-CL A864909106CL A96,630$667,000thousands by filing date
FIBROCELL SCIENCE INC315721209COM NEW157,769$629,000thousands by filing date
CEMPRA INC15130J109COM50,000$537,000thousands by filing date
ZOGENIX INC98978L105COM250,000$503,000thousands by filing date
GALMED PHARMACEUTICALS LTDM47238106SHS50,000$487,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM75,000$478,000thousands by filing date
BIOTA PHARMACEUTIALS INC090694100COM145,507$415,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK100,000$363,000thousands by filing date
CELSION CORPORATION COM PAR15117N404Stock100,000$347,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM16,464$242,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW41,666$199,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-14-004398this filing2014-08-13acceptance time not in the bulk data set